40
Participants
Start Date
November 1, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2026
Thermoneutral condition
Participants will be exposed 2 hours/day at 32ºC for 5 days/week
Cold condition
Participants will be exposed 2 hours/day at 18ºC for 5 days/week
Aerobic exercise condition
Participants will perform aerobic exercise training 5 days/week at 65% heart rate reserve for 60 minutes each training session
Salbutamol
Participants will take salbutamol 12 mg/day. 7 days week
Universidad de Almería, Almería
Leiden University Medical Center
OTHER
ETH Zurich (Switzerland)
OTHER
Universidad de Almeria
OTHER